8EJD image
Entry Detail
PDB ID:
8EJD
EMDB ID:
Keywords:
Title:
Structure of lineage IV Lassa virus glycoprotein complex (strain Josiah)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-09-16
Release Date:
2023-06-07
Method Details:
Experimental Method:
Resolution:
3.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Glycoprotein G1
Mutations:R207C, L258R, L259R
Chain IDs:A (auth: C), C (auth: A), E (auth: B)
Chain Length:406
Number of Molecules:3
Biological Source:Lassa mammarenavirus
Polymer Type:polypeptide(L)
Description:Glycoprotein G2
Mutations:E329P, G360C
Chain IDs:B (auth: c), D (auth: a), F (auth: b)
Chain Length:406
Number of Molecules:3
Biological Source:Lassa mammarenavirus
Ligand Molecules
Primary Citation
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies.
Cell Rep 42 112524 112524 (2023)
PMID: 37209096 DOI: 10.1016/j.celrep.2023.112524

Abstact

Lassa fever is an acute hemorrhagic fever caused by the zoonotic Lassa virus (LASV). The LASV glycoprotein complex (GPC) mediates viral entry and is the sole target for neutralizing antibodies. Immunogen design is complicated by the metastable nature of recombinant GPCs and the antigenic differences among phylogenetically distinct LASV lineages. Despite the sequence diversity of the GPC, structures of most lineages are lacking. We present the development and characterization of prefusion-stabilized, trimeric GPCs of LASV lineages II, V, and VII, revealing structural conservation despite sequence diversity. High-resolution structures and biophysical characterization of the GPC in complex with GP1-A-specific antibodies suggest their neutralization mechanisms. Finally, we present the isolation and characterization of a trimer-preferring neutralizing antibody belonging to the GPC-B competition group with an epitope that spans adjacent protomers and includes the fusion peptide. Our work provides molecular detail information on LASV antigenic diversity and will guide efforts to design pan-LASV vaccines.

Legend

Protein

Chemical

Disease

Primary Citation of related structures